Table 1.

Patient characteristics.

			Mean target coverage
Patient Id	Cancer type	Low tumor sourcea	Low tumor	High tumor	Peripheral blood
GBM-003	GBM	NEB	183	387	177
GBM-005	GBM	NEB	482	404	144
GBM-006	GBM	NEB	441	248	115
GBM-008	GBM	NEB	203	424	186
GBM-009	GBM	NEB	199	387	153
GBM-014	GBM	NEB	223	366	114
GBM-016	GBM	NEB	416	376	261
BHH01	Breast	ANWS	255	268	NA
BHH02	Breast	ANMD	296	350	NA
BHH03	Breast	ANMD	228	302	NA
BHH04	Breast	ANMD	269	296	NA
BHH06	Breast	ANMD	249	336	NA
BHH09	Breast	ANMD	312	290	NA
BHH11	Breast	ANMD	249	282	NA
BHH15	Breast	ANWS	211	323	NA
BHH16	Breast	ANWS	294	289	NA
BHH21	Breast	ANMD	286	331	NA
BHH22	Breast	ANWS	226	301	NA
BHH24	Breast	ANWS	229	297	NA
BHH25	Breast	ANWS	278	275	NA
BHH26	Breast	ANMD	301	291	NA
BHH27	Breast	ANWS	236	328	NA
BHH28	Breast	ANWS	275	264	NA
BHH08	Breast	ANWS	286	288	NA
BHH18	Breast	ANWS	287	261	NA
BHH20	Breast	ANWS	185	326	NA
BHH23	Breast	ANWS	273	243	NA
HHP01	Prostate	ANWS	202	216	NA
HHP02	Prostate	ANWS	206	221	NA
HHP03	Prostate	ANWS	261	184	NA
HHP04	Prostate	ANWS	312	241	NA
HHP05	Prostate	ANWS	247	232	NA
HHP06	Prostate	ANWS	294	214	NA
HHP07	Prostate	ANWS	265	254	NA
HHP08	Prostate	ANWS	287	247	NA
HHP09	Prostate	ANWS	302	228	NA
HHP10	Prostate	ANWS	328	277	NA
HHP11	Prostate	ANWS	329	274	NA
HHP12	Prostate	ANWS	238	239	NA
HHP13	Prostate	ANWS	299	285	NA
HHP14	Prostate	ANWS	269	269	NA
HHP16	Prostate	ANWS	363	330	NA
HHP17	Prostate	ANWS	255	316	NA
HHP18	Prostate	ANWS	224	258	NA
HHP19	Prostate	ANWS	241	281	NA
HHP20	Prostate	ANWS	208	307	NA
HHP21	Prostate	ANWS	213	263	NA

^aNEB, non-enhancing biopsy; ANWS, adjacent normal whole slide; ANMD, adjacent normal macrodissected.